Form 8-K - Current report:
SEC Accession No. 0001628280-25-037441
Filing Date
2025-08-04
Accepted
2025-08-04 16:22:58
Documents
16
Period of Report
2025-08-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ardx-20250801.htm   iXBRL 8-K 31249
2 EX-3.1 ardx-20250630xexhibit31.htm EX-3.1 230272
3 EX-99.1 ardx-20250630xexhibit991.htm EX-99.1 114707
7 ardx-20250801_g1.jpg GRAPHIC 75659
8 picture1.jpg GRAPHIC 19078
  Complete submission text file 0001628280-25-037441.txt   759448

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ardx-20250801.xsd EX-101.SCH 1782
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ardx-20250801_lab.xml EX-101.LAB 23451
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ardx-20250801_pre.xml EX-101.PRE 13581
18 EXTRACTED XBRL INSTANCE DOCUMENT ardx-20250801_htm.xml XML 2895
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36485 | Film No.: 251180606
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)